Guidance on blood clot treatment

NICE has published final guidance recommending the use of prasugrel in combination with aspirin as an option for preventing blood clots in the arteries of people with acute coronary syndromes.

The guidance recommends prasugrel in combination with aspirin as an option for individuals who are having percutaneous coronary intervention, only when immediate primary percutaneous coronary intervention for ST-segmentelevation myocardial infarction (a specific type of heart attack) is necessary; or a blood clot blocking a stent has occurred during treatment with clopidogrel; or the patient has diabetes mellitus. People currently receiving prasugrel for treatment of acute coronary syndromes whose circumstances do not meet these criteria should have the option to continue therapy until they and their clinicians consider it appropriate to stop.

Latest Issues

AfPP Annual National Conference

University of Warwick
8th - 9th August 2025

IGPP Annual Operating Theatres Show

Manchester, Etihad Stadium
11th September 2025

Clinical Engineering Conference

Stansted Radisson Blu
23rd September 2025

Infection Prevention 2025

Brighton Centre, UK
29th - 30th September 2025

CSC Autumn Meeting

Ramada Plaza, Wrexham
13th October 2025